Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NEK2 |
| Upstream (Parents) |
|---|
| (<<) TTK → NEK2 |
| Downstream (Children) |
|---|
| NEK2 → CENPE (>>) |
| NEK2 → CHAF1B (>>) |
| NEK2 → RACGAP1 (>>) |
| NEK2 → C5orf30 (>>) |
| NEK2 → PSRC1 (>>) |
| NEK2 → KNTC1 (>>) |
| NEK2 → TTK (>>) |
| NEK2 → TOP2A (>>) |
| NEK2 → CDC20 (>>) |
| NEK2 → HMMR (>>) |
| NEK2 → CCNB2 (>>) |
| NEK2 → FANCI (>>) |
| NEK2 → SLC35F2 (>>) |
| NEK2 → AURKA (>>) |
| NEK2 → BRCA2 (>>) |
